NEW YORK, Jan 5 - The U.S. Patent and Trade Office reaffirmed its broad policy of patenting genes Friday, issuing a set of guidelines that respond to a variety of concerns about the patentability of genetic information.

“DNA compounds having naturally occurring sequences are eligible for patenting when isolated from their natural state and purified and when the application meets the statutory criteria for patentability,” the guidelines said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.